HIV fusion and its inhibition.
Publication
, Journal Article
LaBranche, CC; Galasso, G; Moore, JP; Bolognesi, DP; Hirsch, MS; Hammer, SM
Published in: Antiviral Res
May 2001
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Antiviral Res
DOI
ISSN
0166-3542
Publication Date
May 2001
Volume
50
Issue
2
Start / End Page
95 / 115
Location
Netherlands
Related Subject Headings
- Virology
- Receptors, HIV
- Peptide Fragments
- Membrane Fusion
- Humans
- Heterocyclic Compounds
- HIV Infections
- HIV Envelope Protein gp41
- HIV
- Enfuvirtide
Citation
APA
Chicago
ICMJE
MLA
NLM
LaBranche, C. C., Galasso, G., Moore, J. P., Bolognesi, D. P., Hirsch, M. S., & Hammer, S. M. (2001). HIV fusion and its inhibition. Antiviral Res, 50(2), 95–115. https://doi.org/10.1016/s0166-3542(01)00130-9
LaBranche, C. C., G. Galasso, J. P. Moore, D. P. Bolognesi, M. S. Hirsch, and S. M. Hammer. “HIV fusion and its inhibition.” Antiviral Res 50, no. 2 (May 2001): 95–115. https://doi.org/10.1016/s0166-3542(01)00130-9.
LaBranche CC, Galasso G, Moore JP, Bolognesi DP, Hirsch MS, Hammer SM. HIV fusion and its inhibition. Antiviral Res. 2001 May;50(2):95–115.
LaBranche, C. C., et al. “HIV fusion and its inhibition.” Antiviral Res, vol. 50, no. 2, May 2001, pp. 95–115. Pubmed, doi:10.1016/s0166-3542(01)00130-9.
LaBranche CC, Galasso G, Moore JP, Bolognesi DP, Hirsch MS, Hammer SM. HIV fusion and its inhibition. Antiviral Res. 2001 May;50(2):95–115.
Published In
Antiviral Res
DOI
ISSN
0166-3542
Publication Date
May 2001
Volume
50
Issue
2
Start / End Page
95 / 115
Location
Netherlands
Related Subject Headings
- Virology
- Receptors, HIV
- Peptide Fragments
- Membrane Fusion
- Humans
- Heterocyclic Compounds
- HIV Infections
- HIV Envelope Protein gp41
- HIV
- Enfuvirtide